SXW
Lv31
388 积分
2025-06-07 加入
-
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
45分钟前
已完结
-
Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials
4小时前
已完结
-
Discovery, Optimization, and Evaluation of Novel ANGPTL3 Modulators for the Treatment of Hyperlipidemia
17天前
已完结
-
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
-
The targeted protein degradation landscape
1个月前
已完结
-
Tumour-derived small extracellular vesicles act as a barrier to therapeutic nanoparticle delivery
1个月前
已完结
-
Multiple-dose clinical pharmacology of ACT-541468, a novel dual orexin receptor antagonist, following repeated-dose morning and evening administration
1个月前
已完结
-
Bridging Olaparib Capsule and Tablet Formulations Using Population Pharmacokinetic Meta-analysis in Oncology Patients
1个月前
已完结
-
Pharmacological issues concerning olaparib capsule and tablet formulations in treating ovarian cancer: Are they really the same drug?
1个月前
已完结
-
A Randomized Phase 1 Evaluation of Deupirfenidone, a Novel Deuterium‐Containing Drug Candidate for Interstitial Lung Disease and Other Inflammatory and Fibrotic Diseases
1个月前
已完结